These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27638140)

  • 1. Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: comment.
    Pengo V
    J Thromb Haemost; 2016 Dec; 14(12):2561-2562. PubMed ID: 27638140
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: reply.
    Lackner KJ; Müller-Calleja N
    J Thromb Haemost; 2016 Dec; 14(12):2563-2564. PubMed ID: 27696707
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma.
    Lackner KJ; Müller-Calleja N
    J Thromb Haemost; 2016 Jun; 14(6):1117-20. PubMed ID: 26998919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of anti-phosphatidylserine/prothrombin antibodies in antiphospholipid syndrome: Still matter of debate. Comment on: "Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis".
    Vandevelde A; Devreese KMJ
    Thromb Res; 2022 Oct; 218():169-170. PubMed ID: 36057166
    [No Abstract]   [Full Text] [Related]  

  • 5. Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromes.
    Asherson RA; Pierangeli S; Cervera R
    J Rheumatol; 2007 Sep; 34(9):1793-5. PubMed ID: 17787048
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al.
    Korkmaz C
    Arthritis Rheum; 2005 Mar; 52(3):988-9; author reply 989-90. PubMed ID: 15751054
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on: Kidney disease in primary antiphospholipid antibody syndrome.
    Korkmaz C; Cansu DU
    Rheumatology (Oxford); 2018 Feb; 57(2):403. PubMed ID: 29126313
    [No Abstract]   [Full Text] [Related]  

  • 8. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
    Cervera R; Rodríguez-Pintó I; Legault K; Erkan D
    Lupus; 2020 Oct; 29(12):1594-1600. PubMed ID: 32819183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cofactor-Independent Antiphospholipid Antibodies: Implications for Pathogenesis, Diagnosis, and Treatment of Antiphospholipid Syndrome.
    Lackner KJ; Müller-Calleja N
    Hamostaseologie; 2019 Jun; 39(2):188-194. PubMed ID: 30419590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory criteria for antiphospholipid syndrome: comment.
    Lackner KJ; Müller-Calleja N
    J Thromb Haemost; 2018 Oct; 16(10):2115-2116. PubMed ID: 30007114
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelets and the antiphospholipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies and the antiphospholipid syndrome. I: pathogenesis, clinical features, diagnosis, and management. Preface.
    Wong RC; Favaloro EJ
    Semin Thromb Hemost; 2008 Apr; 34(3):213-8. PubMed ID: 18720300
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiphospholipid antibodies and antiphospholipid syndrome: diagnosis and management].
    García-García C
    Actas Dermosifiliogr; 2007; 98(1):16-23. PubMed ID: 17374329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
    Cervera R; Rodríguez-Pintó I; Colafrancesco S; Conti F; Valesini G; Rosário C; Agmon-Levin N; Shoenfeld Y; Ferrão C; Faria R; Vasconcelos C; Signorelli F; Espinosa G
    Autoimmun Rev; 2014 Jul; 13(7):699-707. PubMed ID: 24657970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of anti-domain 1- β
    Zhang S; Wu Z; Zhang F; Li Y
    J Thromb Haemost; 2016 Oct; 14(10):2076-2078. PubMed ID: 27455394
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on: "The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome".
    Yazici A; Unlu O; Erkan D
    Thromb Res; 2017 Sep; 157():82-83. PubMed ID: 28711777
    [No Abstract]   [Full Text] [Related]  

  • 17. The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients.
    Salmon JE; Girardi G; Lockshin MD
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):140-7; quiz 1 p following 187. PubMed ID: 17334336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on: "A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies" by Niccolai et al.
    Rodríguez-Carrio J; López Suárez P; Suárez Díaz A
    Thromb Res; 2016 Mar; 139():127. PubMed ID: 26916309
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent Developments in Antiphospholipid Antibodies and the Antiphospholipid Syndrome.
    Urbanus RT
    Semin Thromb Hemost; 2018 Jul; 44(5):417-418. PubMed ID: 29940673
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-Density Granulocytes Are Increased in Antiphospholipid Syndrome and Are Associated With Anti-β2 -Glycoprotein I Antibodies: Comment on the Article by Yalavarthi et al.
    van den Hoogen LL; Fritsch-Stork RD; van Roon JA; Radstake TR
    Arthritis Rheumatol; 2016 May; 68(5):1320-1. PubMed ID: 26749538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.